Search hospitals > Manitoba > WINNIPEG
St. Boniface General Hospital
Claim this profileWINNIPEG, Manitoba R2H 2A6
Global Leader in Heart Failure
Conducts research for Heart Attack
Conducts research for Myocardial Infarction or Heart Attack
Conducts research for Cardiovascular Disease
Conducts research for Bleeding
147 reported clinical trials
14 medical researchers
Summary
St. Boniface General Hospital is a medical facility located in WINNIPEG, Manitoba. This center is recognized for care of Heart Failure, Heart Attack, Myocardial Infarction or Heart Attack, Cardiovascular Disease, Bleeding and other specialties. St. Boniface General Hospital is involved with conducting 147 clinical trials across 201 conditions. There are 14 research doctors associated with this hospital, such as Ashish B. Shah, M.D., Ryan Zarychanski, MD, Thang Nguyen, MD, and Colette Seifer, MD.Top PIs
Ashish B. Shah, M.D.Vanderbilt University Medical Center3 years of reported clinical research
Studies Ankle Arthritis
Studies Arthritis
11 reported clinical trials
14 drugs studied
Ryan Zarychanski, MDSt. Boniface Hospital2 years of reported clinical research
Studies Bleeding
Studies Upper Gastrointestinal Bleeding
4 reported clinical trials
62 drugs studied
Thang Nguyen, MDSt. Boniface Hospital5 years of reported clinical research
Studies Breast Cancer
Studies Cardiovascular Disease
2 reported clinical trials
3 drugs studied
Colette Seifer, MDSt. Boniface Hospital11 years of reported clinical research
Studies Atrial Fibrillation
Studies Heart Failure
2 reported clinical trials
3 drugs studied
Clinical Trials running at St. Boniface General Hospital
Bleeding
Heart Failure
Pneumonia
Coronary Artery Disease
Left Ventricular Dysfunction
Frailty
Malnutrition
Staph Infection
Bacterial Blood Infection
Staph Bacteremia
DOAC vs Warfarin as Blood Thinners After Heart Surgery
for undefined
The DANCE Trial is a multi-centre, randomized controlled trial comparing the safety of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) in the early period (30 days) after cardiac surgery in patients with atrial fibrillation requiring oral anticoagulation.
Recruiting3 awards Phase 34 criteria
Bentracimab
for Bleeding or Emergency Surgery
This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with bentracimab (PB2452) in patients who present with uncontrolled major or life-threatening bleeding or who require urgent surgery or invasive procedure. At least 200 patients will be enrolled from approximately 200 centers in North America, Europe, and Asia-Pacific regions, including mainland China. Patients with reported use of ticagrelor within the prior 3 days who require urgent ticagrelor reversal will be eligible for enrollment. These populations will be enrolled based on separate inclusion criteria.
Recruiting2 awards Phase 310 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at St. Boniface General Hospital?
St. Boniface General Hospital is a medical facility located in WINNIPEG, Manitoba. This center is recognized for care of Heart Failure, Heart Attack, Myocardial Infarction or Heart Attack, Cardiovascular Disease, Bleeding and other specialties. St. Boniface General Hospital is involved with conducting 147 clinical trials across 201 conditions. There are 14 research doctors associated with this hospital, such as Ashish B. Shah, M.D., Ryan Zarychanski, MD, Thang Nguyen, MD, and Colette Seifer, MD.